| Zydus Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532321 |
NSE Symbol : ZYDUSLIFE |
P/E(TTM) : 19.21 |
|
ISIN Demat : INE010B01027 |
Div & Yield% : 1.19 |
EPS(TTM) : 47.96 |
|
Book Value(₹) : 215.08 |
Market Cap(₹Cr) : 92,699.31 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,808.80 | 2,495.80 | 5,633.50 | 2,408.90 | 2,512.30 | 4,035.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,808.80 | 2,495.80 | 5,633.50 | 2,408.90 | 2,512.30 | 4,035.40 |
| Other Operating Income | 62.40 | 92.50 | 186.10 | 107.00 | 108.30 | 124.80 |
| Other Income | 541.50 | 157.10 | 185.40 | 77.50 | 326.70 | 106.60 |
| Total Income | 3,412.70 | 2,745.40 | 6,005.00 | 2,593.40 | 2,947.30 | 4,266.80 |
| Total Expenditure | 1,719.30 | 2,002.90 | 2,046.90 | 1,867.40 | 1,678.40 | 1,787.30 |
| PBIDT | 1,693.40 | 742.50 | 3,958.10 | 726.00 | 1,268.90 | 2,479.50 |
| Interest | 113.80 | 137.60 | 155.40 | 97.20 | 95.90 | 115.40 |
| PBDT | 1,579.60 | 604.90 | 3,802.70 | 628.80 | 1,173.00 | 2,364.10 |
| Depreciation | 136.00 | 130.00 | 128.00 | 131.60 | 133.70 | 130.60 |
| Tax | 281.70 | 89.60 | 826.50 | -24.20 | 248.60 | 531.60 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.30 | 0.60 | 34.50 | 50.80 | 0.90 | 1.10 |
| Reported Profit After Tax | 1,156.60 | 384.70 | 2,813.70 | 470.60 | 789.80 | 1,700.80 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1,156.60 | 384.70 | 2,813.70 | 470.60 | 789.80 | 1,700.80 |
| EPS (Unit Curr.) | 11.49 | 3.82 | 27.96 | 4.68 | 7.85 | 16.90 |
| EPS (Adj) (Unit Curr.) | 11.49 | 3.82 | 27.96 | 4.68 | 7.85 | 16.90 |
| Calculated EPS (Unit Curr.) | 11.50 | 3.82 | 27.97 | 4.68 | 7.85 | 16.91 |
| Calculated EPS (Adj) (Unit Curr.) | 11.50 | 3.82 | 27.97 | 4.68 | 7.85 | 16.91 |
| Calculated EPS (Ann.) (Unit Curr.) | 45.99 | 15.30 | 111.88 | 18.71 | 31.40 | 67.63 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 45.99 | 15.30 | 111.88 | 18.71 | 31.40 | 67.63 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 100.60 | 100.60 | 100.60 | 100.60 | 100.60 | 100.60 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 60.29 | 29.75 | 70.26 | 30.14 | 50.51 | 61.44 |
| PBDTM(%) | 56.24 | 24.24 | 67.50 | 26.10 | 46.69 | 58.58 |
| PATM(%) | 41.18 | 15.41 | 49.95 | 19.54 | 31.44 | 42.15 |